Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A.
Manufacture of pharmaceutical preparations
Overview
Instytut Biotechnologii Surowic I Szczepionek Biom is a Polish pharmaceutical and biotechnology company that produces biological medicines, specialized probiotics, rehydration solutions, and in vitro microbiological diagnostic products. They manufacture a variety of vaccines, including a unique vaccine against Pseudomonas aeruginosa, and ensure high-quality standards through GMP practices. The company collaborates with partners from dozens of countries, providing support for registration, promotion, and distribution of their products.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 1997-01-01. Active
82 1090 1665 0000 0001 5017 2295- 10 1090 1665 0000 0001 5041 6673
- 15 1090 1665 0000 0001 5068 8765
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
27 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| May 20, 2026 | Shareholders' meeting convened | |
| May 21, 2025 | Shareholders' meeting convened | |
| May 16, 2024 | Shareholders' meeting convened | |
| May 15, 2023 | Shareholders' meeting convened | |
| Jun 24, 2022 | Shareholders' meeting convened |
Public aid
6 public aid cases recorded, with a total value of $3,257,419.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 31, 2026 | Regional investment aid | $2,463,433 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Mar 31, 2026 | Training aid | $2,904 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Oct 17, 2024 | Aid for research and development projects: experimental development | $517,956 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-02-01 | Automatyzacja i cyfryzacja procesu wytwarzania szczepionek krytycznych DTP, Clodivac, Tetana, DT, D, d i TyT, w celu wzmocnienia odporności łańcucha dostaw UE | $2,466,337 | Fundusze Europejskie dla Nowoczesnej Gospodarki |
Tenders
99 tenders recorded as contractor: 57 national ($451,971) and 42 EU ($44,239,912).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 1, 2026 | Dostawa leków różnych | — | Wojewódzki Szpital Specjalistyczny We Wrocławiu | |
| Sep 29, 2026 | WOFiTM/8/2026/PN Dostawa szczepionek w latach 2026-2028 | — | Wojskowy Ośrodek Farmacji i Techniki Medycznej - Celestynów | |
| Sep 15, 2026 | Szczepionka błoniczo-tężcowo-krztuścowa (DTP), do szczepień obowiązkowych dzieci do 2 roku życia oraz na rezerwę określoną w rozporządzeniu epidemicznym. Części: 1-3; znak postępowania: ZZP.ZP.411.125.2026 | — | Ministerstwo Zdrowia |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Integrated permit | Active |
Authorized Representatives
Manner of representation
Joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will and sign on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Anna Barbara Flis (52)  | Prezes zarządu instytutu biotechnologii surowic i szczepionek biomed spółka akcyjna |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | |
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | |
| BiotonS.A. | $72,911,351.08 | bioton.com | |
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | |
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | |
| Poznańskie Zakłady Zielarskie HerbapolS.A. | $31,668,225.77 | herbapol.poznan.pl | |
| VipharmS.A. | $30,660,173.61 | vipharm.pl | |
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | |
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | |
| Przedsiębiorstwo Produkcyjno-Handlowe EwaS.A. | $14,322,437.53 | ewa-sa.pl |
Change history
| Date | Event |
|---|---|
| 2012-11-13 | Share capital change (8,200,000.00 PLN → 8,032,700.00 PLN) |
| 2009-12-23 | Name change (Instytut Biotechnologii Surowic I Szczepionek "biomed" Spółka Akcyjna - Skrót Firmy Ibss Biomed S.a. → Instytut Biotechnologii Surowic I Szczepionek Biomed Spółka Akcyjna - Skrót Firmy Ibss Biomed S.a.) |
| 2005-07-21 | Name change (Instytut Biotechnologii Surowic I Szczepionek Biomed → Instytut Biotechnologii Surowic I Szczepionek "biomed" Spółka Akcyjna - Skrót Firmy Ibss Biomed S.a.) |
| 2004-11-09 | Share capital change (6,500,000.00 PLN → 8,200,000.00 PLN) |
| 2003-08-19 | Name change (Wytwórnia Surowic I Szczepionek "biomed" → Instytut Biotechnologii Surowic I Szczepionek Biomed) |
FAQ
Last updated: 2026-03-20